An iRGD peptide fused superantigen mutant induced tumor-targeting and T lymphocyte infiltrating in cancer immunotherapy

Publication date: Available online 4 June 2020Source: International Journal of PharmaceuticsAuthor(s): Yubo Song, Mingkai Xu, Yongqiang Li, Yansheng Li, Wu Gu, Gulinare Halimu, Xuanhe Fu, Huiwen Zhang, Chenggang Zhang
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research